Maternal plasma miRNAs as biomarkers during mid-pregnancy to predict later spontaneous preterm birth: a pilot study

Abstract More than 10% of babies are born too early resulting in over 15 million preterm births and more than one million new-born deaths globally. Although women with a previous spontaneous preterm birth (SPTB) are considered at high risk for recurrence, the majority occur in women without prior hi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Clint Gray, Lesley M. McCowan, Rachna Patel, Rennae S. Taylor, Mark H. Vickers
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/99b47d649112468a9612024b6f1e7043
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:99b47d649112468a9612024b6f1e7043
record_format dspace
spelling oai:doaj.org-article:99b47d649112468a9612024b6f1e70432021-12-02T15:05:22ZMaternal plasma miRNAs as biomarkers during mid-pregnancy to predict later spontaneous preterm birth: a pilot study10.1038/s41598-017-00713-82045-2322https://doaj.org/article/99b47d649112468a9612024b6f1e70432017-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-00713-8https://doaj.org/toc/2045-2322Abstract More than 10% of babies are born too early resulting in over 15 million preterm births and more than one million new-born deaths globally. Although women with a previous spontaneous preterm birth (SPTB) are considered at high risk for recurrence, the majority occur in women without prior history. Prediction of SPTB risk allows for improved care and potential for targeting novel and existing therapeutics to prevent SPTB, which may result in improved outcomes for infant and mother. In this pilot study, a miRNA array was used to analyse plasma from healthy women in their first pregnancy at 20 weeks of gestation who then went on to deliver either at term or experience SPTB at 28–32 weeks. We identified specific miRNA expression profiles that differentiated between those mothers who delivered at term or delivered following SPTB. miR302b, miR1253 and a clustering of miR548 miRNAs were underexpressed in SPTB cases compared to term controls. Conversely, miR223 was elevated in mothers that later experienced a SPTB. The circulating miRNAs identified in the present study may therefore be attractive candidates as non-invasive biomarkers for the early prediction of SPTB. Further larger studies are now warranted to investigate the potential clinical utility of these markers.Clint GrayLesley M. McCowanRachna PatelRennae S. TaylorMark H. VickersNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-7 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Clint Gray
Lesley M. McCowan
Rachna Patel
Rennae S. Taylor
Mark H. Vickers
Maternal plasma miRNAs as biomarkers during mid-pregnancy to predict later spontaneous preterm birth: a pilot study
description Abstract More than 10% of babies are born too early resulting in over 15 million preterm births and more than one million new-born deaths globally. Although women with a previous spontaneous preterm birth (SPTB) are considered at high risk for recurrence, the majority occur in women without prior history. Prediction of SPTB risk allows for improved care and potential for targeting novel and existing therapeutics to prevent SPTB, which may result in improved outcomes for infant and mother. In this pilot study, a miRNA array was used to analyse plasma from healthy women in their first pregnancy at 20 weeks of gestation who then went on to deliver either at term or experience SPTB at 28–32 weeks. We identified specific miRNA expression profiles that differentiated between those mothers who delivered at term or delivered following SPTB. miR302b, miR1253 and a clustering of miR548 miRNAs were underexpressed in SPTB cases compared to term controls. Conversely, miR223 was elevated in mothers that later experienced a SPTB. The circulating miRNAs identified in the present study may therefore be attractive candidates as non-invasive biomarkers for the early prediction of SPTB. Further larger studies are now warranted to investigate the potential clinical utility of these markers.
format article
author Clint Gray
Lesley M. McCowan
Rachna Patel
Rennae S. Taylor
Mark H. Vickers
author_facet Clint Gray
Lesley M. McCowan
Rachna Patel
Rennae S. Taylor
Mark H. Vickers
author_sort Clint Gray
title Maternal plasma miRNAs as biomarkers during mid-pregnancy to predict later spontaneous preterm birth: a pilot study
title_short Maternal plasma miRNAs as biomarkers during mid-pregnancy to predict later spontaneous preterm birth: a pilot study
title_full Maternal plasma miRNAs as biomarkers during mid-pregnancy to predict later spontaneous preterm birth: a pilot study
title_fullStr Maternal plasma miRNAs as biomarkers during mid-pregnancy to predict later spontaneous preterm birth: a pilot study
title_full_unstemmed Maternal plasma miRNAs as biomarkers during mid-pregnancy to predict later spontaneous preterm birth: a pilot study
title_sort maternal plasma mirnas as biomarkers during mid-pregnancy to predict later spontaneous preterm birth: a pilot study
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/99b47d649112468a9612024b6f1e7043
work_keys_str_mv AT clintgray maternalplasmamirnasasbiomarkersduringmidpregnancytopredictlaterspontaneouspretermbirthapilotstudy
AT lesleymmccowan maternalplasmamirnasasbiomarkersduringmidpregnancytopredictlaterspontaneouspretermbirthapilotstudy
AT rachnapatel maternalplasmamirnasasbiomarkersduringmidpregnancytopredictlaterspontaneouspretermbirthapilotstudy
AT rennaestaylor maternalplasmamirnasasbiomarkersduringmidpregnancytopredictlaterspontaneouspretermbirthapilotstudy
AT markhvickers maternalplasmamirnasasbiomarkersduringmidpregnancytopredictlaterspontaneouspretermbirthapilotstudy
_version_ 1718388848159883264